Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT05608044	TitleA Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer Without Liver Metastases	Fase Fase 2	Date Added 2022-11-08	Ubicación Arizona, United States California, United States Colorado, United States Delaware, United States Florida, United States Massachusetts, United States Michigan, United States New Jersey, United States New York, United States Ohio, United States Oregon, United States Rhode Island, United States Tennessee, United States Texas, United States Virginia, United States Washington, United States Bélgica Brasil Francia Georgia Italia Russian Federation España	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Balstilimab, Botensilimab, Regorafenib, TAS-102	Etiquetas MSS/ MMRp
NCT ID NCT04895709	TitleEstudio de BMS-986340 como monoterapia y en combinación con nivolumab en participantes con tumores sólidos avanzados.	Fase Phase 1, Phase 2	Date Added 2021-05-20	Ubicación California, United States Iowa, United States New Jersey, United States New York, United States Oregon, United States Tennessee, United States Texas, United States Australia Canadá Alemania Israel Italia Japón España	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas BMS-936558-01, BMS-986340	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03400332	TitleEstudio de BMS-986253 en combinación con nivolumab o nivolumab más ipilimumab en cánceres avanzados.	Fase Fase 2	Date Added 2018-01-17	Ubicación Arkansas, United States California, United States Colorado, United States Georgia, United States Maryland, United States Massachusetts, United States Michigan, United States Nebraska, United States Nevada, United States New Jersey, United States New York, United States Oklahoma, United States Oregon, United States Pennsylvania, United States South Carolina, United States Texas, United States Utah, United States Virginia, United States Australia Bélgica Canadá Francia Alemania Italia Polonia España Suecia Suiza Reino Unido	Prior IO Allowed No	CRC-directed No	Status Activo, no recluta	Drogas BMS-986253, Ipilimumab, Nivolumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03289962	TitleA Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors	Fase Fase 1	Date Added 2017-09-21	Ubicación Arizona, United States California, United States Colorado, United States Connecticut, United States Massachusetts, United States Nevada, United States New York, United States Oklahoma, United States Oregon, United States Tennessee, United States Washington, United States Bélgica Canadá Alemania Países Bajos España Suecia Reino Unido	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas Atezolizumab, Autogene cevumeran, Tecentriq	Etiquetas MSS/ MMRp
NCT ID NCT05684211	TitleUn estudio de ametumumab en combinación con un anticuerpo monoclonal anti-PD-1 y FOLFIRI en pacientes con cáncer colorrectal avanzado de tipo RAS salvaje	Fase Fase 2	Date Added 2023-01-13	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Aún no se ha contratado	Drogas Ametumumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05167409	TitleA Study of ALX148 With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer	Fase Fase 2	Date Added 2021-12-22	Ubicación Arizona, United States Colorado, United States New Jersey, United States Virginia, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas ALX148, cetuximab, Evorpacept (ALX148), Pembrolizumab, Erbitux, Keytruda	Etiquetas MSS/ MMRp
NCT ID NCT05382442	TitleA Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer	Fase Fase 2	Date Added 2022-05-19	Ubicación California, United States China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas 5-Fluorouracil, Bevacizumab, capecitabine, Irinotecan, Leucovorin, oxaliplatin	Etiquetas MSS/ MMRp
NCT ID NCT02988960	TitleA Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors	Fase Fase 1	Date Added 2016-12-12	Ubicación California, United States Illinois, United States Massachusetts, United States North Carolina, United States Tennessee, United States Texas, United States Virginia, United States Australia Canadá Francia Japón Corea, República de España	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas ABBV-181, ABBV-927, Opdivo	Etiquetas MSS/ MMRp
NCT ID NCT05141721	TitleA Study of a Personalized Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer	Fase Fase 2	Date Added 2021-12-02	Ubicación Arizona, United States Arkansas, United States California, United States Colorado, United States Connecticut, United States Florida, United States Illinois, United States Indiana, United States Kansas, United States Kentucky, United States Maryland, United States Michigan, United States Nevada, United States New Jersey, United States New York, United States Ohio, United States Oregon, United States Pennsylvania, United States South Carolina, United States Tennessee, United States Texas, United States Utah, United States Virginia, United States Wisconsin, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Atezolizumab, Bevacizumab, Fluoropyrimidine, GRT-C901, GRT-R902, Ipilimumab, oxaliplatin	Etiquetas MSS/ MMRp
NCT ID VAPER	TitleA study looking at using a vaccine and chemotherapy to treat advanced cancer	Fase Fase 1	Date Added 2015-11-17	Ubicación	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas Celecoxib, Cyclophosphamide, imiquimod, vaccine	Etiquetas MSS/ MMRp

Showing 271 to 280 of 299 entries